Literature DB >> 33530449

Diagnosis of Lynch Syndrome and Strategies to Distinguish Lynch-Related Tumors from Sporadic MSI/dMMR Tumors.

Julie Leclerc1,2,3,4, Catherine Vermaut1, Marie-Pierre Buisine1,2,3,4.   

Abstract

Microsatellite instability (MSI) is a hallmark of Lynch syndrome (LS)-related tumors but is not specific to it, as approximately 80% of MSI/mismatch repair-deficient (dMMR) tumors are sporadic. Methods leading to the diagnosis of LS have considerably evolved in recent years and so have tumoral tests for LS screening and for the discrimination of LS-related to MSI-sporadic tumors. In this review, we address the hallmarks of LS, including the clinical, histopathological, and molecular features. We present recent advances in diagnostic and screening strategies to identify LS patients. We also discuss the pitfalls associated with the current strategies, which should be taken into account to improve the diagnosis of LS and avoid inappropriate clinical management.

Entities:  

Keywords:  BRAF mutation; Lynch syndrome; MLH1 promoter methylation; microsatellite instability; mismatch repair genes

Year:  2021        PMID: 33530449      PMCID: PMC7865821          DOI: 10.3390/cancers13030467

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  297 in total

Review 1.  Finding the needle in a haystack: identification of cases of Lynch syndrome with MLH1 epimutation.

Authors:  Megan P Hitchins
Journal:  Fam Cancer       Date:  2016-07       Impact factor: 2.375

2.  Coexisting somatic promoter hypermethylation and pathogenic MLH1 germline mutation in Lynch syndrome.

Authors:  N Rahner; N Friedrichs; V Steinke; S Aretz; W Friedl; R Buettner; E Mangold; P Propping; C Walldorf
Journal:  J Pathol       Date:  2008-01       Impact factor: 7.996

3.  Microsatellite instability and DNA mismatch repair protein deficiency in Lynch syndrome colorectal polyps.

Authors:  Matthew B Yurgelun; Ajay Goel; Jason L Hornick; Ananda Sen; Danielle Kim Turgeon; Mack T Ruffin; Norman E Marcon; John A Baron; Robert S Bresalier; Sapna Syngal; Dean E Brenner; C Richard Boland; Elena M Stoffel
Journal:  Cancer Prev Res (Phila)       Date:  2012-01-18

4.  PMS2 gene mutational analysis: direct cDNA sequencing to circumvent pseudogene interference.

Authors:  Katharina Wimmer; Annekatrin Wernstedt
Journal:  Methods Mol Biol       Date:  2014

5.  Novel strategy for optimal sequential application of clinical criteria, immunohistochemistry and microsatellite analysis in the diagnosis of hereditary nonpolyposis colorectal cancer.

Authors:  Christoph Engel; Jochen Forberg; Elke Holinski-Feder; Constanze Pagenstecher; Jens Plaschke; Matthias Kloor; Christopher Poremba; Christian P Pox; Josef Rüschoff; Gisela Keller; Wolfgang Dietmaier; Petra Rümmele; Nicolaus Friedrichs; Elisabeth Mangold; Reinhard Buettner; Hans K Schackert; Peter Kienle; Susanne Stemmler; Gabriela Moeslein; Markus Loeffler
Journal:  Int J Cancer       Date:  2006-01-01       Impact factor: 7.396

6.  ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach.

Authors:  C Luchini; F Bibeau; M J L Ligtenberg; N Singh; A Nottegar; T Bosse; R Miller; N Riaz; J-Y Douillard; F Andre; A Scarpa
Journal:  Ann Oncol       Date:  2019-08-01       Impact factor: 32.976

Review 7.  A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.

Authors:  C R Boland; S N Thibodeau; S R Hamilton; D Sidransky; J R Eshleman; R W Burt; S J Meltzer; M A Rodriguez-Bigas; R Fodde; G N Ranzani; S Srivastava
Journal:  Cancer Res       Date:  1998-11-15       Impact factor: 12.701

8.  Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorectal cancer.

Authors:  M B Loughrey; P M Waring; A Tan; M Trivett; S Kovalenko; V Beshay; M-A Young; G McArthur; A Boussioutas; A Dobrovic
Journal:  Fam Cancer       Date:  2007-04-24       Impact factor: 2.375

9.  Clinicopathological characteristics of patients with upper urinary tract urothelial cancer with loss of immunohistochemical expression of the DNA mismatch repair proteins in universal screening.

Authors:  Shinji Urakami; Naoko Inoshita; Suguru Oka; Yu Miyama; Sachio Nomura; Masami Arai; Kazushige Sakaguchi; Kazuhiro Kurosawa; Toshikazu Okaneya
Journal:  Int J Urol       Date:  2017-11-22       Impact factor: 3.369

10.  Evaluation of microsatellite instability and immunohistochemistry for the prediction of germ-line MSH2 and MLH1 mutations in hereditary nonpolyposis colon cancer families.

Authors:  Siobhan S Wahlberg; James Schmeits; George Thomas; Massimo Loda; Judy Garber; Sapna Syngal; Richard D Kolodner; Edward Fox
Journal:  Cancer Res       Date:  2002-06-15       Impact factor: 12.701

View more
  15 in total

1.  Familial Lynch syndrome with early age of onset and confirmed splice site mutation in MSH2: A case report.

Authors:  Zornitsa Bogomilova Kamburova; Savelina Lubenova Popovska; Katya Stefanova Kovacheva; Krasimir Todorov Petrov; Slavena Enkova Nikolova
Journal:  Biomed Rep       Date:  2022-03-14

Review 2.  Neurodevelopmental disorders, immunity, and cancer are connected.

Authors:  Ruth Nussinov; Chung-Jung Tsai; Hyunbum Jang
Journal:  iScience       Date:  2022-05-30

Review 3.  Antioxidative, Anti-Inflammatory, Anti-Obesogenic, and Antidiabetic Properties of Tea Polyphenols-The Positive Impact of Regular Tea Consumption as an Element of Prophylaxis and Pharmacotherapy Support in Endometrial Cancer.

Authors:  Piotr Olcha; Anna Winiarska-Mieczan; Małgorzata Kwiecień; Łukasz Nowakowski; Andrzej Miturski; Andrzej Semczuk; Bożena Kiczorowska; Krzysztof Gałczyński
Journal:  Int J Mol Sci       Date:  2022-06-16       Impact factor: 6.208

4.  The Alteration of T-Cell Heterogeneity and PD-L1 Colocalization During dMMR Colorectal Cancer Progression Defined by Multiplex Immunohistochemistry.

Authors:  Hongkai Yan; Yaqi Li; Xiaoyu Wang; Juanjuan Qian; Midie Xu; Junjie Peng; Dan Huang
Journal:  Front Oncol       Date:  2022-05-20       Impact factor: 5.738

Review 5.  Endometrial Cancer Management in Young Women.

Authors:  Anna Markowska; Anita Chudecka-Głaz; Kazimierz Pityński; Włodzimierz Baranowski; Janina Markowska; Włodzimierz Sawicki
Journal:  Cancers (Basel)       Date:  2022-04-11       Impact factor: 6.575

6.  How can same-gene mutations promote both cancer and developmental disorders?

Authors:  Ruth Nussinov; Chung-Jung Tsai; Hyunbum Jang
Journal:  Sci Adv       Date:  2022-01-14       Impact factor: 14.136

7.  Mismatch Repair Deficiency and Somatic Mutations in Human Sinonasal Tumors.

Authors:  Lena Hieggelke; Carina Heydt; Roberta Castiglione; Jan Rehker; Sabine Merkelbach-Bruse; Cristina Riobello; José Luis Llorente; Mario A Hermsen; Reinhard Buettner
Journal:  Cancers (Basel)       Date:  2021-12-02       Impact factor: 6.639

8.  Impact of Different Selection Approaches for Identifying Lynch Syndrome-Related Colorectal Cancer Patients: Unity Is Strength.

Authors:  Daniele Fanale; Lidia Rita Corsini; Chiara Brando; Alessandra Dimino; Clarissa Filorizzo; Luigi Magrin; Roberta Sciacchitano; Alessia Fiorino; Tancredi Didier Bazan Russo; Valentina Calò; Juan Lucio Iovanna; Edoardo Francini; Antonio Russo; Viviana Bazan
Journal:  Front Oncol       Date:  2022-02-09       Impact factor: 6.244

Review 9.  Lynch-like Syndrome: Potential Mechanisms and Management.

Authors:  Alejandro Martínez-Roca; Mar Giner-Calabuig; Oscar Murcia; Adela Castillejo; José Luis Soto; Anabel García-Heredia; Rodrigo Jover
Journal:  Cancers (Basel)       Date:  2022-02-22       Impact factor: 6.639

Review 10.  Current Prognostic and Predictive Biomarkers for Endometrial Cancer in Clinical Practice: Recommendations/Proposal from the Italian Study Group.

Authors:  Gian Franco Zannoni; Emma Bragantini; Francesca Castiglione; Matteo Fassan; Giancarlo Troncone; Frediano Inzani; Anna Pesci; Angela Santoro; Filippo Fraggetta
Journal:  Front Oncol       Date:  2022-04-08       Impact factor: 5.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.